- Home
- RY vs TMO Comparison
RY vs TMO Comparison
Compare RY & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RY
- TMO
- Stock Information
- Founded
- RY 1864
- TMO 1956
- Country
- RY Canada
- TMO United States
- Employees
- RY N/A
- TMO N/A
- Industry
- RY
- TMO Industrial Machinery/Components
- Sector
- RY
- TMO Industrials
- Exchange
- RY Nasdaq
- TMO Nasdaq
- Market Cap
- RY 185.5B
- TMO 159.1B
- IPO Year
- RY N/A
- TMO N/A
- Fundamental
- Price
- RY $131.79
- TMO $434.67
- Analyst Decision
- RY Buy
- TMO Buy
- Analyst Count
- RY 1
- TMO 17
- Target Price
- RY $193.00
- TMO $591.35
- AVG Volume (30 Days)
- RY 901.2K
- TMO 2.7M
- Earning Date
- RY 08-27-2025
- TMO 07-23-2025
- Dividend Yield
- RY 2.30%
- TMO 0.40%
- EPS Growth
- RY 16.97
- TMO 9.37
- EPS
- RY 9.09
- TMO 17.06
- Revenue
- RY $42,077,115,670.00
- TMO $42,898,000,000.00
- Revenue This Year
- RY $22.04
- TMO $2.96
- Revenue Next Year
- RY $3.31
- TMO $6.01
- P/E Ratio
- RY $14.50
- TMO $25.49
- Revenue Growth
- RY 15.75
- TMO 0.95
- 52 Week Low
- RY $102.89
- TMO $385.46
- 52 Week High
- RY $133.84
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- RY 59.72
- TMO 61.66
- Support Level
- RY $131.38
- TMO $411.88
- Resistance Level
- RY $133.84
- TMO $438.49
- Average True Range (ATR)
- RY 1.34
- TMO 12.39
- MACD
- RY 0.04
- TMO 2.88
- Stochastic Oscillator
- RY 73.79
- TMO 91.60
About RY Royal Bank Of Canada
Royal Bank of Canada is one of the two largest banks in Canada, with around CAD 2.2 trillion in assets. It is a diversified financial services company, offering personal and commercial banking, wealth management, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada and has dominant market shares. RBC also has wealth and capital market businesses in the US, UK, and other countries. RBC is a top 15 investment bank globally.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).